CYP21A2 and congenital adrenal hyperplasia: Since the carrier frequency of CYP21A2 variants is high (1 in 60) in Middle Europe, partners of women with CAH should be informed about the option of genetic testing in order to estimate the risk of severe forms of CAH in offspring including virilisation in female foetuses.